Oncotelic Therapeutics annual free cash flow
2009
2014
2015
Oncotelic Therapeutics Free Cash Flow (FCF) History (OTLC)
Oncotelic Therapeutics reported −$11.9M in free cash flow for fiscal 2015, an increase of $228,000 from the previous fiscal year.
View full Oncotelic Therapeutics company overviewOncotelic Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2015 | 2015-12-31 | −$11.9M | $228,000 | — | — |
| 2014 | 2014-12-31 | −$12.2M | — | — | — |
| 2009 | 2009-12-31 | −$28.8M | — | — | — |
Oncotelic Therapeutics quarterly free cash flow
Q3.15
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2015 | 2015-09-30 | −$2.8M | — | — | — |
Oncotelic Therapeutics free cash flow growth trends
Oncotelic Therapeutics's latest reported quarter, Q3 2015, generated −$2.8M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Oncotelic Therapeutics source filings ↗